Roche Diagnostics CEO
This article was originally published in The Gray Sheet
Martin Madaus, PhD, is slated to become president and CEO of Millipore Corp. by Feb. 1. The 45-year-old recently left Roche Diagnostics, which he led as president and chief exec since 2000. Heino von Prondzynski, head of Roche's diagnostics division in Basel, Switzerland, will assume operational oversight of the team until a permanent replacement is found. Before leaving for Millipore, a Billerica, Mass.-based biosciences company, Madaus chaired AdvaMed's In Vitro Diagnostic sector...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.